These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32647988)

  • 1. Stem Cell Marker Expression in Early Stage Colorectal Cancer is Associated with Recurrent Intestinal Neoplasia.
    Walker BS; Zarour LR; Wieghard N; Gallagher AC; Swain JR; Weinmann S; Lanciault C; Billingsley K; Tsikitis VL; Wong MH
    World J Surg; 2020 Oct; 44(10):3501-3509. PubMed ID: 32647988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mTOR Signaling Combined with Cancer Stem Cell Markers as a Survival Predictor in Stage II Colorectal Cancer.
    Chang JY; Kim JH; Kang J; Park Y; Park SJ; Cheon JH; Kim WH; Kim H; Park JJ; Kim TI
    Yonsei Med J; 2020 Jul; 61(7):572-578. PubMed ID: 32608200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract.
    Levin TG; Powell AE; Davies PS; Silk AD; Dismuke AD; Anderson EC; Swain JR; Wong MH
    Gastroenterology; 2010 Dec; 139(6):2072-2082.e5. PubMed ID: 20826154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant co-expression of putative cancer stem cell markers, EpCAM and CD166, correlates with tumor stage and invasive behavior in colorectal cancer.
    Kalantari E; Taheri T; Fata S; Abolhasani M; Mehrazma M; Madjd Z; Asgari M
    World J Surg Oncol; 2022 Jan; 20(1):15. PubMed ID: 35016698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
    Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
    Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
    Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
    Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cancer stem cell markers in breast phyllodes tumor.
    Kim SI; Koo JS
    Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between markers of colorectal cancer stem cells and adenomas among ethnic groups.
    Leavell BJ; Van Buren E; Antaki F; Axelrod BN; Rambus MA; Majumdar AP
    Dig Dis Sci; 2012 Sep; 57(9):2334-9. PubMed ID: 22562538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.
    Kleist B; Xu L; Li G; Kersten C
    Int J Clin Exp Pathol; 2011 Apr; 4(4):327-35. PubMed ID: 21577318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer.
    Horst D; Kriegl L; Engel J; Kirchner T; Jung A
    Cancer Invest; 2009 Oct; 27(8):844-50. PubMed ID: 19626493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
    Lugli A; Iezzi G; Hostettler I; Muraro MG; Mele V; Tornillo L; Carafa V; Spagnoli G; Terracciano L; Zlobec I
    Br J Cancer; 2010 Jul; 103(3):382-90. PubMed ID: 20606680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
    Wu XS; Xi HQ; Chen L
    World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer.
    Patel BB; Yu Y; Du J; Levi E; Phillip PA; Majumdar AP
    Biochem Biophys Res Commun; 2009 Jan; 378(3):344-7. PubMed ID: 19010307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.